Literature DB >> 18751776

Bone mineral density determinations by dual-energy x-ray absorptiometry in the management of patients with Marfan syndrome--some factors which affect the measurement.

Philip F Giampietro1, Margaret G E Peterson, Robert Schneider, Jessica G Davis, Stephen W Burke, Oheneba Boachie-Adjei, Charles M Mueller, Cathleen L Raggio.   

Abstract

Reduced bone mineral density (BMD) was sporadically reported in patients with Marfan syndrome. This may or may not place the Marfan patient at increased risk for bone fracture. In comparing the BMDs of our patients with those reported in the literature, it seemed that agreement between values, and hence the degree of osteoporosis or osteopenia reported, was dependent on the instrumentation used. The objective of this study was to statistically assess this impression. Bone mineral density measurements from our previously published study of 30 adults with Marfan syndrome performed on a Lunar DPXL machine were compared with studies published between 1993-2000 measured using either Lunar or Hologic bone densitometry instruments. The differences of our measurements compared with those made on other Lunar machines were not statistically significant, but did differ significantly with published results from Hologic machines (P < 0.001). Before progress can be made in the assessment of BMD and fracture risk in Marfan patients and in the evidence-based orthopedic management of these patients, standardization of instrumental bone density determinations will be required along with considerations of height, obesity, age, and sex.

Entities:  

Year:  2007        PMID: 18751776      PMCID: PMC2504097          DOI: 10.1007/s11420-006-9030-3

Source DB:  PubMed          Journal:  HSS J        ISSN: 1556-3316


  25 in total

1.  Protrusio acetabuli and bilateral basicervical femoral neck fractures in a patient with Marfan syndrome.

Authors:  F D Kharrazi; W B Rodgers; D L Coran; J R Kasser; J E Hall
Journal:  Am J Orthop (Belle Mead NJ)       Date:  1997-10

2.  Dual X-ray absorptiometry quality control: comparison of visual examination and process-control charts.

Authors:  Y Lu; A K Mathur; B A Blunt; C C Gluer; A S Will; T P Fuerst; M D Jergas; K N Andriano; S R Cummings; H K Genant
Journal:  J Bone Miner Res       Date:  1996-05       Impact factor: 6.741

3.  Bone mineral density in sixty adult patients with Marfan syndrome.

Authors:  J M Le Parc; P Plantin; G Jondeau; M Goldschild; M Albert; C Boileau
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

4.  Bone mineral density in adults with Marfan syndrome.

Authors:  N Carter; E Duncan; P Wordsworth
Journal:  Rheumatology (Oxford)       Date:  2000-03       Impact factor: 7.580

Review 5.  Bone density in children: a review of the available techniques and indications.

Authors:  V Gilsanz
Journal:  Eur J Radiol       Date:  1998-01       Impact factor: 3.528

6.  Cross-calibration, precision and patient dose measurements in preparation for clinical trials using dual energy X-ray absorptiometry of the lumbar spine.

Authors:  S A Cawte; D Pearson; D J Green; W B Maslanka; C G Miller; A T Rogers
Journal:  Br J Radiol       Date:  1999-04       Impact factor: 3.039

Review 7.  Narrative [corrected] review: bisphosphonates and osteonecrosis of the jaws.

Authors:  Sook-Bin Woo; John W Hellstein; John R Kalmar
Journal:  Ann Intern Med       Date:  2006-05-16       Impact factor: 25.391

8.  Discrepancies in normative data between Lunar and Hologic DXA systems.

Authors:  K G Faulkner; L A Roberts; M R McClung
Journal:  Osteoporos Int       Date:  1996       Impact factor: 4.507

9.  Standardization of bone mineral density at femoral neck, trochanter and Ward's triangle.

Authors:  Y Lu; T Fuerst; S Hui; H K Genant
Journal:  Osteoporos Int       Date:  2001       Impact factor: 4.507

10.  Variability and accuracy in mammographic interpretation using the American College of Radiology Breast Imaging Reporting and Data System.

Authors:  K Kerlikowske; D Grady; J Barclay; S D Frankel; S H Ominsky; E A Sickles; V Ernster
Journal:  J Natl Cancer Inst       Date:  1998-12-02       Impact factor: 13.506

View more
  5 in total

1.  Differential effects of alendronate and losartan therapy on osteopenia and aortic aneurysm in mice with severe Marfan syndrome.

Authors:  Harikiran Nistala; Sui Lee-Arteaga; Luca Carta; Jason R Cook; Silvia Smaldone; Gabriella Siciliano; Aaron N Rifkin; Harry C Dietz; Daniel B Rifkin; Francesco Ramirez
Journal:  Hum Mol Genet       Date:  2010-09-24       Impact factor: 6.150

Review 2.  Diseases affecting bone quality: beyond osteoporosis.

Authors:  Aasis Unnanuntana; Brian J Rebolledo; M Michael Khair; Edward F DiCarlo; Joseph M Lane
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

3.  Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton.

Authors:  Shan Chen; Monica Grover; Tarek Sibai; Jennifer Black; Nahid Rianon; Abbhirami Rajagopal; Elda Munivez; Terry Bertin; Brian Dawson; Yuqing Chen; Ming-Ming Jiang; Brendan Lee; Tao Yang; Yangjin Bae
Journal:  Mol Genet Metab       Date:  2015-02-27       Impact factor: 4.797

Review 4.  The ever-expanding conundrum of primary osteoporosis: aetiopathogenesis, diagnosis, and treatment.

Authors:  Stefano Stagi; Loredana Cavalli; Salvatore Seminara; Maurizio de Martino; Maria Luisa Brandi
Journal:  Ital J Pediatr       Date:  2014-06-07       Impact factor: 2.638

5.  Assessment of bone mineral status in children with Marfan syndrome.

Authors:  Monica Grover; Nicola Brunetti-Pierri; John Belmont; Kelly Phan; Alyssa Tran; Roman J Shypailo; Kenneth J Ellis; Brendan H Lee
Journal:  Am J Med Genet A       Date:  2012-08-07       Impact factor: 2.802

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.